Skip to main content

Translational Neurodegeneration: 10th Anniversary

2022 marks the 10th anniversary of Translational Neurodegeneration.

To celebrate, we have put together a page to review the achievements and highlights of the journal.


  1. Authors: Matilde Bongianni, Mauro Catalan, Daniela Perra, Elena Fontana, Francesco Janes, Claudio Bertolotti, Luca Sacchetto, Stefano Capaldi, Matteo Tagliapietra, Paola Polverino, Valentina Tommasini, Giulia Bellavita, Elham Ataie Kachoie, Roberto Baruca, Andrea Bernardini, Mariarosaria Valente…

    The Correction to this article has been published in Translational Neurodegeneration 2022 11:38


Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

Announcing the launch of In Review

Translational Neurodegeneration, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Affiliated with

Annual Journal Metrics